Curbs Primary Mechanism of Action Increasing GLP-1 Production By now, nearly everyone has heard of Ozempic (semaglutide), an injectable peptide that stimulates the receptor for a hormone called glucagon-like peptide-1 (GLP-1)
S2CID 24759624
References 1.Bailey RA, Wang Y, Zhu V, Rupnow MFT
Dose splitting addresses both problems simultaneously: lower peaks reduce side effects, and higher troughs maintain appetite suppression throughout the week
Key exclusion criteria included other medications impacting weight, unstable medical illness, active substance use disorder, and dual antipsychotic use
In the second phase of human experiments, we found that the mortality caused by its protective treatment was higher than that of the control group (Narayan et al., 2002)